Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year
- 29 February 2008
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 58 (2), 224-231
- https://doi.org/10.1016/j.jaad.2007.07.042
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Interobserver reliability of the Nail Psoriasis Severity IndexClinical and Experimental Dermatology, 2006
- Modification of the nail psoriasis severity indexJournal of the American Academy of Dermatology, 2005
- Remission and time of resolution of nail psoriasis during infliximab therapyJournal of the American Academy of Dermatology, 2005
- Biological therapies in the systemic management of psoriasis: International Consensus ConferenceBritish Journal of Dermatology, 2004
- Psoriatic Nails: A Prospective Clinical StudyJournal of Cutaneous Medicine and Surgery, 2003
- Management of nail psoriasisClinical and Experimental Dermatology, 2000
- A simplified protocol of steroid injection for psoriatic nail dystrophyBritish Journal of Dermatology, 1998
- Psoriasis of the Nails Associated with Disability in a Large Number of Patients: Results of a Recent Interview with 1,728 PatientsDermatology, 1996
- Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvementJournal of the American Academy of Dermatology, 1995
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978